fluoxetine has been researched along with Prostatic Neoplasms in 3 studies
Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.
Prostatic Neoplasms: Tumors or cancer of the PROSTATE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The overexpression of GPM6B in prostate cancer cells could inhibit cell proliferation." | 1.56 | GPM6B Inhibit PCa Proliferation by Blocking Prostate Cancer Cell Serotonin Absorptive Capacity. ( Ding, Y; He, S; Huang, Z; Jia, Z; Li, X; Liu, B; Sheng, H, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Lorenzo-Luaces, L | 1 |
| Rodriguez-Quintana, N | 1 |
| Riley, TN | 1 |
| Weisz, JR | 1 |
| He, S | 1 |
| Huang, Z | 1 |
| Li, X | 1 |
| Ding, Y | 1 |
| Sheng, H | 1 |
| Liu, B | 1 |
| Jia, Z | 1 |
| Abdul, M | 1 |
| Logothetis, CJ | 1 |
| Hoosein, NM | 1 |
1 trial available for fluoxetine and Prostatic Neoplasms
| Article | Year |
|---|---|
A placebo prognostic index (PI) as a moderator of outcomes in the treatment of adolescent depression: Could it inform risk-stratification in treatment with cognitive-behavioral therapy, fluoxetine, or their combination?
Topics: Adolescent; Cognitive Behavioral Therapy; Combined Modality Therapy; Depression; Depressive Disorder | 2021 |
2 other studies available for fluoxetine and Prostatic Neoplasms
| Article | Year |
|---|---|
GPM6B Inhibit PCa Proliferation by Blocking Prostate Cancer Cell Serotonin Absorptive Capacity.
Topics: Biomarkers, Tumor; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Fluoxetine; Gene Expressio | 2020 |
Growth-inhibitory effects of serotonin uptake inhibitors on human prostate carcinoma cell lines.
Topics: Animals; Carcinoma; Cell Division; Dose-Response Relationship, Drug; Fluoxetine; Humans; Male; Mice; | 1995 |